COVID-19
Clinical Microbiology
Environmental Microbiology
Antibiotic Resistance
Bacteria
Viruses
Fungi
About Microbe Musings
Contact
Search
Tech
News
COVID-19
Clinical Microbiology
Environmental Microbiology
Antibiotic Resistance
Bacteria
Viruses
Fungi
About Microbe Musings
Contact
Tech
News
Facebook
Linkedin
Twitter
Youtube
Search
COVID-19
Clinical Microbiology
Environmental Microbiology
Antibiotic Resistance
Bacteria
Viruses
Fungi
About Microbe Musings
Contact
More
Paul Naphtali
Paul Naphtali is a PhD candidate at McMaster University and studies cystic fibrosis respiratory disease driven by bacterial infections. He specializes in the study of Pseudomonas-driven infections with genomics and transcriptomics.
17 articles
Viruses
HIV-B, the new HIV variant identified in Europe
Paul Naphtali
-
March 16, 2022
Clinical Microbiology
Cultured microbes are spearheading a rebirth in microbiology research
Paul Naphtali
-
February 24, 2022
Bacteria
Genome annotation: a decoding project harder than Enigma
Paul Naphtali
-
February 4, 2022
Clinical Microbiology
Sustainable disinfection: working towards an environmentally friendly disinfectant
Paul Naphtali
-
January 29, 2022
COVID-19
A tale of two variants: Omicron BA.2, Deltacron, and the importance of preventing lab contamination
Paul Naphtali
-
January 27, 2022
COVID-19
A picture of Omicron spread in South Africa
Paul Naphtali
-
January 11, 2022
COVID-19
Free-range SARS-Cov-2 infections in free-ranging white-tailed deer
Paul Naphtali
-
December 28, 2021
Antibiotic Resistance
Staying ahead in the fight against antibiotic resistance: Developing a new class of antibiotics
Paul Naphtali
-
December 8, 2021
1
2
3
Page 1 of 3
Stay on op - Ge the daily news in your inbox
Subscribe